Treatment of HIV infection by integrase inhibiting: more options

被引：0

作者：

Raffi, Francois ^{[1
]}

Wainberg, Mark A. ^{[2
]}

机构：

[1] Hop Nantes, EA 4271, F-44093 Nantes 1, France

[2] McGill Univ, Jewish Gen Hosp, AIDS Ctr, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada

来源：

VIROLOGIE | 2013年 / 17卷 / 02期

关键词：

CO-FORMULATED ELVITEGRAVIR; TWICE-DAILY RALTEGRAVIR; DOUBLE-BLIND; INITIAL TREATMENT; PHASE-3; RESISTANCE; PHARMACOKINETICS; EMTRICITABINE; COBICISTAT; TENOFOVIR;

D O I：

暂无

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：54 / 60

页数：7

共 26 条

[1]

Abram ME, 2012, INT WORKSH HIV HEP V

[2]

[Anonymous], 19 INT AIDS C WASH D

[3] Comparative biochemical analysis of HIV-1 subtype B and C integrase enzymes [J].

Bar-Magen, Tamara ;

Sloan, Richard D. ;

Faltenbacher, Verena H. ;

Donahue, Daniel A. ;

Kuhl, Bjoern D. ;

Oliveira, Maureen ;

Xu, Hongtao ;

Wainberg, Mark A. .

RETROVIROLOGY, 2009, 6

[4] HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications [J].

Blanco, Jose-Luis ;

Varghese, Vici ;

Rhee, Soo-Yon ;

Gatell, Jose M. ;

Shafer, Robert W. .

JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (09) :1204-1214

[5]

Cavassini M, 2012, J ACQUIR IMMUNE DEFI

[6] Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial [J].

DeJesus, Edwin ;

Rockstroh, Juergen K. ;

Henry, Keith ;

Molina, Jean-Michel ;

Gathe, Joseph ;

Ramanathan, Srinivasan ;

Wei, Xuelian ;

Yale, Kitty ;

Szwarcberg, Javier ;

White, Kirsten ;

Cheng, Andrew K. ;

Kearney, Brian P. .

LANCET, 2012, 379 (9835) :2429-2438

[7] Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial [J].

Eron, Joseph J., Jr. ;

Rockstroh, Juergen K. ;

Reynes, Jacques ;

Andrade-Villanueva, Jaime ;

Ramalho-Madruga, Jose Valdez ;

Bekker, Linda-Gail ;

Young, Benjamin ;

Katlama, Christine ;

Maria Gatell-Artigas, Jose ;

Arribas, Jose R. ;

Nelson, Mark ;

Campbell, Havilland ;

Zhao, Jing ;

Rodgers, Anthony J. ;

Rizk, Matthew L. ;

Wenning, Larissa ;

Miller, Michael D. ;

Hazuda, Daria ;

DiNubile, Mark J. ;

Leavitt, Randi ;

Isaacs, Robin ;

Robertson, Michael N. ;

Sklar, Peter ;

Nguyen, Bach-Yen .

LANCET INFECTIOUS DISEASES, 2011, 11 (12) :907-915

[8]

Johnson Victoria A, 2011, Top Antivir Med, V19, P156

[9] In Vitro Antiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor [J].

Kobayashi, Masanori ;

Yoshinaga, Tomokazu ;

Seki, Takahiro ;

Wakasa-Morimoto, Chiaki ;

Brown, Kevin W. ;

Ferris, Robert ;

Foster, Scott A. ;

Hazen, Richard J. ;

Miki, Shigeru ;

Suyama-Kagitani, Akemi ;

Kawauchi-Miki, Shinobu ;

Taishi, Teruhiko ;

Kawasuji, Takashi ;

Johns, Brian A. ;

Underwood, Mark R. ;

Garvey, Edward P. ;

Sato, Akihiko ;

Fujiwara, Tamio .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (02) :813-821

[10] Differential Sensitivities of Retroviruses to Integrase Strand Transfer Inhibitors [J].

Koh, Yasuhiro ;

Matreyek, Kenneth A. ;

Engelman, Alan .

JOURNAL OF VIROLOGY, 2011, 85 (07) :3677-3682

← 1 2 3 →